38 Results for "

Tankyrases

" in MedChemExpress (MCE) Product Catalog:
Products (38)

38 Results for "Tankyrases" in MCE Product Catalog:

190
190 Publications Verification
Cat. No.: HY-15147
CAS No.: 284028-89-3
Pureté:  99.80%
Target:  

β-catenin PARP

Domaines de recherche:  

Cancer

XAV-939 is a Tankyrase inhibitor. XAV-939 has inhibitory activity for TNKS1 and TNKS2 with IC50 values of 5 nM and 2 nM, respectively. XAV-939 also is an enhancer of osteoblastic differentiation of hMSCs. XAV-939 can be used for the research of conditions associated with activated Wnt signaling, such as cancer, fibrotic diseases and conditions associated with low bone formation .
62
62 Cited Publications
Cat. No.: HY-12238
CAS No.: 1127442-82-3
Pureté:  99.60%
Synonyms: endo-IWR 1; IWR-1-endo
Target:  

Organoid Wnt

Domaines de recherche:  

Inflammation/Immunology Cancer

IWR-1 (IWR-1-endo) is a tankyrase inhibitor targeting Wnt/β-catenin (IC50 = 180 nM). IWR-1 compromises critical steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets. IWR-1 promotes β-catenin phosphorylation by promoting stability of Axin-scaffolded destruction complexes. IWR-1 can be studied in research for anti-tumor purposes, and diseases such as osteosarcoma, colorectal cancer and psoriasis .
5
5 Cited Publications
Cat. No.: HY-13968
CAS No.: 664993-53-7
Pureté:  99.83%
Target:  

PARP

Domaines de recherche:  

Cancer

JW 55 is a potent and selective β-catenin signaling pathway inhibitor, which functions via inhibition of the PARP domain of tankyrase 1 and tankyrase 2 (TNKS1/2). JW 55 decreases auto-PARsylation of TNKS1/2 in vitro with IC50s of 1.9 μM and 830 nM respectively.
5
5 Cited Publications
Cat. No.: HY-16910
CAS No.: 838818-26-1
Target:  

PARP β-catenin Wnt

Domaines de recherche:  

Cancer

WIKI4 is a potent tankyrase inhibitor with an IC50 of 26 nM for TNKS2. WIKI4 potently inhibits Wnt/β-catenin signaling and that its half-maximal response dose is 75 nM. WIKI4 mediates its effects on Wnt/β-catenin signaling by inhibiting the enzymatic activity of TNKS2 . WIKI4 is cytotoxic to SCLC cells with an IC50 value of 0.02 μM .
3
3 Cited Publications
Cat. No.: HY-19351
CAS No.: 92831-11-3
Target:  

PARP

Domaines de recherche:  

Cancer

MN-64 is a potent tankyrase 1 inhibitor, with IC50s of 6 nM, 72 nM, 19.1 μM, and 39.4 μM for TNKS1, TNKS2, ARTD1 and ARTD2, respectively.
2
2 Cited Publications
Cat. No.: HY-U00422
CAS No.: 130017-40-2
Target:  

PARP

Domaines de recherche:  

Cancer

K-756 is a direct and selective tankyrase (TNKS) inhibitor, which inhibits the ADP-ribosylation activity of TNKS1 and TNKS2 with IC50s of 31 and 36 nM, respectively.
1
1 Cited Publications
Cat. No.: HY-123892
CAS No.: 2171386-10-8
Pureté:  99.80%
Target:  

PARP

Domaines de recherche:  

Cancer

RK-287107 is a potent and specific tankyrase inhibitor with IC50s of 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively. RK-287107 blocks colorectal cancer cell growth .
Cat. No.: HY-147245
CAS No.: 1858179-75-5
Pureté:  98.49%
Synonyms: STP1002
Target:  

PARP

Domaines de recherche:  

Cancer

Basroparib (STP1002) is a selective, orally active inhibitor of tankyrase (TNKS1/TNKS2) with IC50 of 29.94 nM and 3.68 nM for TNKS1 and TNKS2, respectively. Basroparib has an IC50 of >10 μM for PARP1. Basroparib binds to TNKS, stabilizes AXIN1/2 proteins, blocks Wnt/β-catenin signaling pathway, inhibits tumor cell proliferation and induces apoptosis, while reducing cancer stem cell properties. Basroparib can be used in colorectal cancer (CRC) studies with KRAS mutations (such as G12V/G12D) to overcome acquired resistance to MEK inhibitors. STP1002 has synergistic antitumor activity with MEK inhibitors .
Cat. No.: HY-137849
CAS No.: 2171388-28-4
Target:  

PARP

Domaines de recherche:  

Cancer

RK-582 is a tankyrase inhibitor, antitumor agent, and orally bioavailable growth inhibitor, with an IC50 of 36.1 nM against human tankyrase-1 and an IC50 of 39.2 nM against human tankyrase-2. In APC-mutated colorectal cancer cells, the sensitivity to RK-582 correlates with the level of active β-catenin, while drug resistance associates with PIK3CA mutation. RK-582 can be used for the research of colorectal cancer .
Cat. No.: HY-145584
CAS No.: 2055357-64-5
Pureté:  99.54%
Synonyms: JPI-547/OCN-201
Target:  

PARP Wnt β-catenin

Domaines de recherche:  

Neurological Disease Cancer

Nesuparib (JPI-547) is the orally active inhibitor for PARP 1/2 and Tankyrase 1/2 that inhibits tankyrases 1, tankyrases 2, and PARP 1 with IC50s of 5, 1 and 2 nM, respectively. Nesuparib exhibits antitumor activity and can be used in research of advanced solid tumor .
Cat. No.: HY-145267
CAS No.: 2406278-81-5
Pureté:  99.59%
Target:  

PARP Wnt

Domaines de recherche:  

Cancer

OM-153 is a potent and orally active tankyrase inhibitor with IC50s of 13 nM and 2 nM for tankyrase 1 and tankyrase 2 (TNKS1/2), respectively. OM-153 inhibits luciferase-based Wnt/β-catenin signaling reporter activity with an IC50 value of 0.63 nM. OM-153 shows inhibition of Wnt/β-catenin signaling and proliferation in COLO 320DM .
Cat. No.: HY-123851
CAS No.: 1460286-21-8
Pureté:  98.50%
Synonyms: M2912
Target:  

PARP

Domaines de recherche:  

Cancer

MSC2504877 (M2912) is a potent and orally active tankyrase inhibitor with IC50s of 0.0007, 0.0008, 0.54 µM for TNKS, TNKS2, PARP1, respectively. MSC2504877 increases the expression of AXIN2 and TNKS protein levels and decreases β-catenin levels. MSC2504877 shows anti-tumor activity .
Cat. No.: HY-164478
CAS No.: 1507370-78-6
Target:  

PARP Wnt β-catenin

Domaines de recherche:  

Cancer

G-631 is an orally active tankyrase(TNKS1/TNKS2) inhibitor. G-631 stabilizes AXIN and inhibits the Wnt/β-catenin signaling pathway. G-631 can be used in studies related to cancers such as colorectal cancer .
Cat. No.: HY-15147G
CAS No.: 284028-89-3
XAV-939 (GMP) is XAV-939 (HY-15347) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. XAV-939 is a tankyrase inhibitor .
Cat. No.: HY-117705
CAS No.: 1563007-08-8
Pureté:  98.88%
Target:  

Wnt PARP

Domaines de recherche:  

Cancer

G244-LM is a potent and specific inhibitor of tankyrase 1/2 that inhibits Wnt signaling .
Cat. No.: HY-126248
CAS No.: 1588870-36-3
Pureté:  99.06%
Target:  

PARP Wnt

Domaines de recherche:  

Cancer

Tankyrase-IN-2 (compound 5k) is a potent, selective, and orally active tankyrase inhibitor (IC50s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively). Tankyrase-IN-2 has favorable physicochemical profile and pharmacokinetic properties modulating Wnt pathway activity in a colorectal xenograft model .
Cat. No.: HY-108437
CAS No.: 1127442-87-8
Pureté:  98.75%
Target:  

Wnt

Domaines de recherche:  

Infection Cancer

exo-IWR-1, an inactive stereoisomer of Endo-IWR-1, is a negative control of IWR-1 (HY-12238). IWR-1 is a tankyrase inhibitor which inhibits Wnt/β-catenin signaling pathway .
Cat. No.: HY-152197
CAS No.: 938893-79-9
Target:  

PARP

Domaines de recherche:  

Cancer

Tankyrase-IN-3 is a tankyrase 1 (TNKS1) inhibitor with an IC50 value of 22 nM. Tankyrase-IN-3 can be used for the research of cancer .
Cat. No.: HY-15147R
CAS No.: 284028-89-3
Target:  

β-catenin PARP

Domaines de recherche:  

Cancer

XAV-939 (Standard) is the analytical standard of XAV-939. This product is intended for research and analytical applications. XAV-939 is a Tankyrase inhibitor. XAV-939 has inhibitory activity for TNKS1 and TNKS2 with IC50 values of 5 nM and 2 nM, respectively. XAV-939 also is an enhancer of osteoblastic differentiation of hMSCs. XAV-939 can be used for the research of conditions associated with activated Wnt signaling, such as cancer, fibrotic diseases and conditions associated with low bone formation .
Cat. No.: HY-16910G
CAS No.: 838818-26-1
WIKI4 (GMP) is WIKI4 (HY-16910) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. WIKI4 is a potent tankyrase inhibitor .